TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ErGe BioTech AB
Closing information (x1000 SEK)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
1,427
|
1,308
|
1,352 |
Financial expenses |
1
![]() |
1
|
0 |
Earnings before taxes |
506
|
456
|
475 |
EBITDA |
507
|
457
|
475 |
Total assets |
1,832
|
1,495
|
1,216 |
Current assets |
805
|
468
|
339 |
Current liabilities |
166
|
229
|
290 |
Equity capital |
1,541
|
1,146
|
886 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
84.1%
|
76.7%
|
72.9% |
Turnover per employee |
1,427
|
654
|
676 |
Profit as a percentage of turnover |
35.5%
|
34.9%
|
35.1% |
Return on assets (ROA) |
27.7%
|
30.6%
|
39.1% |
Current ratio |
484.9%
|
204.4%
|
116.9% |
Return on equity (ROE) |
32.8%
|
39.8%
|
53.6% |
Change turnover |
119
|
-44
|
43 |
Change turnover % |
9%
|
-3%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.